A Retrospective Study Comparing Nose, Lip, and Chin Morphology in Class I, Class II, and Class III Skeletal Relationships in Patients Visiting to the Department of Orthodontics, BPKIHS: A Cephalometric Study.

Background: With the changing paradigm from primarily hard tissue to soft tissue evaluation for orthodontic diagnosis and treatment planning, the priority has shifted to bring about improvement in the profile and smile characteristics of patients. Since not only the esthetics but also the stability of orthodontic treatment is largely determined by the soft tissue envelope, proper positioning of the soft tissue drape becomes paramount. Soft tissues of face, namely, nose, lips, and chin, are of paramount importance not only from an esthetic but also from functional and treatment stability points. Objective: To determine the morphological variation of lips, nose, and chin in different skeletal malocclusions. Materials and Methods: Lateral cephalograms of 237 patients visiting the department of orthodontics, BPKIHS, were taken, hand traced on matt acetate tracing paper of 0.002″ thickness with 0.3-mm 2B pencil. Samples were divided into 3 skeletal classes based on ANB angle. Measurements were made in relation to the nose, lips, and chin. Data were inserted in to SPSS and analyzed statistically using descriptive statistics, and mean and standard deviation was calculated for each variable. Multiple comparison between groups was done with post hoc Bonferroni test with mean difference significant at p < 0.05. Result: On intergroup comparison, a significant difference was found for upper lip thickness (ULT) between Class II and Class III, and lower lip length (LLL) between Class I and Class III, and between Class II and Class III. Significant difference for nasolabial angle (NLA) was found between Class II and Class III. Similarly, a significant difference for the vertical chin parameter (CTV) was found between Class I and Class III, and between Class II and Class III. Conclusion: Both upper and lower lip thicknesses were highest for Class III followed by Class I and Class II, respectively. Lip lengths too were found to be highest for Class III skeletal relation. Nasolabial angle was larger in Class II malocclusion when compared to Class I and Class III. Similarly, both nasal length and nasal height measurements were in the order of Class III > Class II > Class I. Both horizontal and vertical chin parameters were larger for Class III sagittal relation.

Thermite reaction driven pyrotechnic formulation with promising functional performance and reduced emissions.

Green pyrotechnics/firecrackers reported herein are driven by thermite reactions for self-contained and self-sustained exothermic chemical reactions to make heat and sound by the usage of minimal fuel (aluminum), oxidizer (potassium nitrate), and Sulfur. These firecrackers have the potential for generating less emissions (70%) compared to commercial firecracker-based counterparts due to the presence of additives and are therefore designated as "Green firecrackers" or reduced emissions firecrackers. The functional performance and long-term stability of the composition was investigated through sound measurement and different tests, including ageing, thermal stability, and moisture test. The thermodynamics of the facilitated thermite reaction was cross-checked with experimental and theoretical methods. Prevalent mechanism for a substantial reduction in emissions to the tune of about 70% has been discussed. Cost of the green firecrackers is at par with the commercial firecrackers as cost of raw materials being used to prepare the formulation is comparable to the relatively toxic oxidizer substituted. "Green firecrackers" developed and reported here are environmentally benign in nature with higher business potential as far as a green chemistry-based sustainable solution for the society is required.

Development of Darunavir proliposome powder for oral delivery by using Box-Bhenken design.

The aim of this study is to develop Darunavir (DRV) proliposome powder for oral delivery. Darunavir-loaded oral proliposome powder (OPP) was prepared by a solvent evaporation technique with varying independent variables at three different levels. Based on different levels, proliposome powder formulation was optimized by using Box-Behnken design. The formulations were analyzed for its size distribution, entrapment efficiency, and surface morphology. Optimized proliposome batch A was evaluated for physical parameter, morphological parameters, entrapment efficiency, followed by in vitro, ex vivo, and in vivo studies. Oral proliposome powder showed good micromeritic properties with angle of repose was less than 30°, Carr's index and Hausner's ratio were also less than 21 and 1.25, respectively. The mean size of the vesicles was in the range of 180-290 nm. The assay and entrapment efficiency of pro-liposome powder formulations were 79.00 ± 0.2 and 93.46 ± 0.2%, respectively. In vitro release of DRV proliposome powder was 78.17 ± 0.1% after 24 h which shows good release from the vesicle of proliposome. Ex vivo permeation study shows 58.11% enhancement which shows good permeation. The optimize batch A of proliposome powder indicated 50% enhancement in the relative bioavailability as compared to the DRV suspension. The results showed that proliposome powder containing DRV can efficiently deliver in to the blood stream. This drug delivery system has been designed as a novel platform for potential oral delivery of drugs having poor water solubility and high first-pass metabolism.

Development of α-glucosidase inhibitors by room temperature C-C cross couplings of quinazolinones.

Novel quinazolinone based α-glucosidase inhibitors have been developed. For this purpose a virtual screening model has been generated and validated utilizing acarbose as a α-glucosidase inhibitor. Homology modeling, docking, and virtual screening were successfully employed to discover a set of structurally diverse compounds active against α-glucosidase. A search of a 3D database containing 22,500 small molecules using the structure based virtual model yielded ten possible candidates. All ten candidates were N-3-pyridyl-2-cyclopropyl quinazolinone-4-one derivatives, varying at the 6 position. This position was modified by Suzuki-Miyaura cross coupling with aryl, heteroaryl, and alkyl boronic acids. A catalyst screen was performed, and using the best optimal conditions, a series of twenty five compounds was synthesized. Notably, the C-C cross coupling reactions of the 6-bromo-2-cyclopropyl-3-(pyridyl-3-ylmethyl)quinazolin-4(3H)-one precursor have been accomplished at room temperature. A comparison of the relative reactivities of 6-bromo and 6-chloro-2,3-disubstituted quinazolinones with phenyl boronic acid was conducted. An investigation of pre-catalyst loading for the reaction of the 6-bromo-2-cyclopropyl-3-(pyridyl-3-ylmethyl)quinazolin-4(3H)-one substrate was also carried out. Finally, we submitted our compounds to biological assays against α-glucosidase inhibitors. Of these, three hits (compounds 4a, 4t and 4r) were potentially active as α-glucosidase inhibitors and showed activity with IC50 values <20 µM. Based on structural novelty and desirable drug-like properties, 4a was selected for structure-activity relationship study, and thirteen analogs were synthesized. Nine out of thirteen analogs acted as α-glucosidase inhibitors with IC50 values <10 µM. These lead compounds have desirable physicochemical properties and are excellent candidates for further optimization.

C-C cross-coupling reactions of O6-alkyl-2-haloinosine derivatives and a one-pot cross-coupling/O6-deprotection procedure.

Reaction conditions for the CC cross-coupling of O(6)-alkyl-2-bromo- and 2-chloroinosine derivatives with aryl-, hetaryl-, and alkylboronic acids were studied. Optimization experiments with silyl-protected 2-bromo-O(6)-methylinosine led to the identification of [PdCl(2)(dcpf)]/K(3)PO(4) in 1,4-dioxane as the best conditions for these reactions (dcpf=1,1'-bis(dicyclohexylphosphino)ferrocene). Attempted O(6)-demethylation, as well as the replacement of the C-6 methoxy group by amines, was unsuccessful, which led to the consideration of Pd-cleavable groups such that C-C cross-coupling and O(6)-deprotection could be accomplished in a single step. Thus, inosine 2-chloro-O(6)-allylinosine was chosen as the substrate and, after re-evaluation of the cross-coupling conditions with 2-chloro-O(6)-methylinosine as a model substrate, one-step C-C cross-coupling/deprotection reactions were performed with the O(6)-allyl analogue. These reactions are the first such examples of a one-pot procedure for the modification and deprotection of purine nucleosides under C-C cross-coupling conditions.